Viewing Study NCT03429465



Ignite Creation Date: 2024-05-06 @ 11:03 AM
Last Modification Date: 2024-10-26 @ 12:40 PM
Study NCT ID: NCT03429465
Status: COMPLETED
Last Update Posted: 2018-08-08
First Post: 2018-02-05

Brief Title: Training Resiliency in Youth TRY Study
Sponsor: University of Washington
Organization: University of Washington

Study Overview

Official Title: Training Resiliency in Youth TRY Study
Status: COMPLETED
Status Verified Date: 2018-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TRY
Brief Summary: The aim of the study is to determine whether a neuroscience-inspired cognitive remediation video game EVO that targets the cognitive control network CCN will improve executive functioning EF and resilience to psychiatric symptoms in typically developing 6th grade students unselected for specific psychiatric symptoms The primary goals are to 1 determine if EVO will result in improved EF and lower internalizing eg mood anxiety and externalizing eg attention deficithyperactivity disorder ADHD psychiatric symptoms 2 evaluate whether the benefit experienced by youth changes depending on their level of life stress eg academic or social difficulties 3 determine if EVO will promote resilience to stress The investigators will measure EF symptoms and stress using self- and parent-report questionnaires Other secondary outcomes include information on behavior in the classroom and academic performance ie grades that we will collect via school records The investigators hypothesize that engagement with EVO 20-minutes per day 5-days a week across 4-weeks will improve EF lower psychiatric symptoms improve academicbehavioral functioning at school and decrease maladaptive responses to stress
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None